CLEVELAND, Sept. 22 /PRNewswire/ -- The Cleveland Clinic Lerner Research
Institute will host a national summit in October to explore innovative
strategies for translating nanotechnology, the field of tiny technology, into
biomedical research and clinical devices to benefit patient care.
The Cleveland Clinic NanoMedicine Summit 2004 will take place Oct. 25-26
at the InterContinental Hotel and MBNA Conference Center Cleveland. The event
will kickoff Cleveland NANO Week and is being presented in collaboration with
Case Western Reserve University, Cornell University and the Maple Fund. The
summit will offer insight from top nanotechnology experts and draw biomedical
researchers and leading practitioners in the fields of cardiology, neurology,
oncology and orthopaedics.
Derek Raghavan, M.D., Ph.D., chairman of The Cleveland Clinic Taussig
Cancer Center, and Harold Craighead, co-director of the Nanotechnology Center
at Cornell University, are the event's plenary speakers. The two-day event
will include two lunchtime forums highlighting the perspective of high-profile
industry experts on the role of nanotechnology in their fields.
"This summit will bring together top nanoscientists from around the
country and leading biomedical researchers and clinician investigators to
explore the feasibility of applying nanotechnology solutions to fill unmet
clinical needs," said Shuvo Roy, Ph.D., a biomedical engineer and researcher
at The Cleveland Clinic Lerner Research Institute. Dr. Roy is leading the
summit's organizing committee. "This is a great show of the capabilities of
nanotechnology at The Cleveland Clinic and throughout the biotech world."
Nanotechnology combines chemistry, physics, and engineering to develop new
materials and devices by manipulating matter at the molecular scale to produce
the precise structures needed. The materials and devices have dimensions that
are smaller than a few hundred nanometers, or billionths of a meter. The field
promises to offer revolutionary new opportunities in healthcare technology.
The Oct. 25 lunchtime panel will cover nanotechnology in relation to
medical devices. Panelists will include Youseph Yazdi, corporate director of
science and technology for Johnson & Johnson; Joseph Smith, chief medical
officer of cardiac rhythm management for Guidant Corp.; Michael Helmus, vice
president of advanced biomaterials and corporate research for Boston
Scientific Corp.; and Paul Citron, vice president of science and technology
for Medtronic Inc.
"The Cleveland Clinic NanoMedicine Summit is unique in focusing more
closely on the clinical applications and clinicians than other nanotechnology
meetings," said Mr. Yazdi of Johnson & Johnson. "This focus is critical in
providing a reality check in this rapidly developing field."
The Oct. 26 lunchtime panel will focus on nanotechnology in relation to
the pharmaceutical industry. In addition to Mr. Yazdi, panelists will include
Mostafa Analoui, senior director and global head of computational medicine and
clinical technology for Pfizer Global Research and Development; Stephen de
Laszlo, director of strategic platform technologies and external scientific
affairs for Merck Research Laboratories; and Margaret Blohm of GE Medical.
Expert presentations and panel forums at the summit will highlight state-
of-the-art biomedical nanotechnology, discuss specifications for nanoscale
tools for biomedical research, and identify unmet clinical needs ripe for
nanobiotechnology solutions. Attendees will have opportunities to network at
two receptions where exhibitors will also demonstrate the latest
nanotechnoloqy equipment for biomedical research and clinical applications.
Topics to be covered at the summit include:
* Nanotechnology concepts relevant to clinical medicine and biomedical
* Current research tools for molecular biology -- noninvasive imaging,
tissue engineering, neuroscience, clinical pathology and molecular
* Unmet clinical needs in neurological, cardiovascular, orthopaedic and
* Nanoscale technologies including quantum dots, biosensors, cell
sorters, drug delivery, biomimetic scaffolds, AFM manipulation, genetic
sequencing, carbon nanotubes, nanopatterned substrates and cell
Upon attending the summit, attendees will be able to:
* Recognize terms and concepts that characterize current nanotechnology
* Distinguish between top-down and bottom-up nanofabrication strategies.
* Identify nanoscale tools under development that will enhance biomedical
* Understand potential of nanobiotechnology to address unmet clinical
* Determine high-impact opportunities for nanotechnology in medicine.
* Develop strategies to translate nanotechnology into clinical practice.
Physicians attending the summit will be able to earn up to 15 Type 1 CME
(continuing medical education) credits towards the AMA Physicians Recognition
Award. Category 2 CME credits for the American Osteopathic Association are
The Lerner Research Institute is home to The Cleveland Clinic's basic
research departments comprising approximately 130 principal investigators.
With total annual research expenditures exceeding $150 million from federal
agencies, non-federal societies and associations and endowment funds, the
Lerner Research Institute is the fifth largest research institute in the
The Cleveland Clinic Foundation, located in Cleveland, Ohio, is a
not-for-profit multispecialty academic medical center that integrates clinical
and hospital care with research and education. The Cleveland Clinic was
founded in 1921 by four renowned physicians with a vision of providing
outstanding patient care based upon the principles of cooperation, compassion
and innovation. U.S. News & World Report consistently names The Cleveland
Clinic as one of the nation's best hospitals in its annual "America's Best
Hospitals" survey. Approximately 1,200 full-time salaried physicians at The
Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical
specialties and subspecialties. In 2003, patients came for treatment from
every state and from nearly 90 countries. The Cleveland Clinic website address
is http://www.clevelandclinic.org .
SOURCE The Cleveland Clinic Foundation